Coats Group Reports 1% Organic Revenue Growth in H1 2026 Amid Market Share Gains and Sector Challenges

Strong Market Performance Despite Destocking and Macroeconomic Uncertainty

During the first half of 2026, Coats Group delivered notable market outperformance amid significant industry challenges such as tariff uncertainties, Middle East conflicts, and customer-driven inventory destocking. The company posted 1% organic revenue growth to $837 million on a constant currency basis, while core apparel and footwear markets contracted by an estimated mid-single-digit percentage. This marks the fourth consecutive period of consistent market share gains across the Group’s portfolio, validating management’s strategic positioning and operational execution during a cyclical downturn.

Group CEO David Paja commented, "We are pleased with our first-half outperformance relative to the market and remain confident in our outlook for the second half, despite the ongoing industry destocking." The company’s ability to uphold pricing discipline and control costs while investing in growth initiatives underscores Coats’ structural advantages, including its global manufacturing footprint and strong customer relationships. Management expects lean inventory levels across customer supply chains may position the company for demand improvements in the latter half of the year beyond current forecasts.

Apparel Division Drives Portfolio Growth with Strength in China and Automotive Markets

The Apparel division, a major part of Group operations, recorded 1% organic revenue growth in H1 2026 amid market uncertainties. It continued to gain market share, notably in the China domestic market and automotive thread segments. The division’s EBIT margin stood at 18.9%, down 50 basis points from H1 2025, primarily due to strategic investments in technology and growth initiatives such as Coats Digital, the company’s SaaS platform serving the apparel sector.

Coats’ market share gains in China domestic and automotive threads reflect its competitive strengths, including unmatched global manufacturing capabilities, proprietary technology platforms, and ongoing innovation. Advanced ordering, planning, and sampling systems combined with precise colour-matching across manufacturing sites differentiate Coats in a consolidated market. Investments in Coats Digital are expected to further enhance competitive positioning by reducing customer lead times and enabling small order quantities, aligning with evolving customer needs in these growth areas.

Footwear Division Returns to Growth in Q2 Following Organizational Restructuring

The Footwear division posted flat organic revenue growth in H1 2026 but returned to solid growth in Q2, demonstrating the effectiveness of the H2 2025 organizational restructuring. This restructuring consolidated the Group into two divisions—Apparel and Footwear—reflecting changes following the exit from the Americas Yarns business and the OrthoLite acquisition. The division’s EBIT margin increased by 30 basis points to 21.1%, including a 70 basis point benefit from OrthoLite. Excluding the acquisition, the margin was slightly lower due to investments in personnel and capabilities offsetting operational efficiency gains.

Q2 growth acceleration was driven by progress on growth initiatives and easier year-on-year comparisons, with outperformance in footwear thread and structural components and strong growth in composite energy tapes. Pasquale Abruzzese was appointed Divisional CEO, and four product profit-and-loss centres with dedicated managing directors were established, alongside a product-focused sales organization. These changes position the division for accelerated growth, supported by a promising new product pipeline expected to launch in H2 2026 and into 2027. Management confirmed the division’s return to organic growth in Q2 despite a declining market, validating the restructuring and talent investments.

Growth in 100% Recycled Thread Sales and Target Adjacencies Boost Revenue

Coats strengthened its leadership in sustainability-focused products, with 100% recycled thread sales rising 11% on a constant currency basis in H1 2026 to $297 million, up from $269 million a year earlier. This category represents a significant and growing part of Group revenue, driven by customer demand for sustainable materials and Coats’ investments in circular economy solutions. The company’s sustainability strategy encompasses emissions, waste, materials, water, and people, with several 2026 commitments achieved a year ahead of schedule.

Target market adjacencies, focusing on faster-growing segments adjacent to core apparel and footwear, contributed 1% to Group revenue growth in H1 2026. These include safety fabrics, composite tapes for energy applications, woven uppers for footwear, and structural components for premium leather handbags, representing an estimated $2 billion addressable market growing over 5% CAGR. Composite tapes for energy markets showed strong growth, supported by new products for oil and gas pipeline and other industrial energy customers. Strategic focus on these adjacencies is expected to enhance structural growth potential beyond traditional markets.

OrthoLite Integration Advances with $5 Million Cost Synergies in 2026 and $40 Million Sales Opportunity by 2030

Eight months post-OrthoLite acquisition, Coats remains confident in the strategic rationale and long-term value creation. The company expects $5 million in cost synergies in 2026, rising to at least $20 million annualized by 2028. Procurement initiatives are delivering in-year benefits, while footprint optimization has started in Indonesia and will extend to China and Vietnam in 2027 and 2028. The Pleret, Indonesia factory will begin producing OrthoLite insoles in Q1 2027, serving as a model for integration by combining Coats’ lean manufacturing with OrthoLite’s technology.

OrthoLite’s sales potential has expanded, with multiple adjacent growth opportunities identified representing a $600 million addressable market by 2030, growing at about 10% annually, incremental to OrthoLite’s existing $1 billion addressable market by 2030. Initiatives include Electrostatic Discharge (ESD) insoles for safety footwear, Supercritical Foam (SCF) insoles for premium running shoes, integrated carbon plate systems combining Coats’ technology with OrthoLite insoles, and Cirql, a patented midsole technology offering premium performance with up to 39% lower carbon footprint. These initiatives are expected to generate at least $40 million incremental annual revenue by 2030, beyond the original acquisition case. Early customer traction is encouraging, with first revenues anticipated in H2 2026 for ESD, SCF, and Cirql, and carbon plate solutions launching in aftermarket in 2027.

Robust Free Cash Flow of $30 Million Despite Market Headwinds and Destocking

Coats generated $30 million in free cash flow in H1 2026, slightly down from $38 million in H1 2025, demonstrating resilience of its capital-light business model. Strong cash generation is attributed to low capital intensity and disciplined working capital management. Management expects strong full-year free cash flow aligned with the $1 billion cumulative target over five years. Net debt rose to $842 million at June 30, 2026, from $815 million at December 31, 2025, mainly due to the full-year 2025 final dividend payment, with leverage at 2.3x net debt to EBITDA. The company remains on track to reduce leverage to 2.0x by year-end, supported by typical H2 seasonal cash flows.

Capital allocation prioritizes deleveraging to a target of 2.0x or below net debt to EBITDA by end-2026. After investing in organic growth and maintaining a progressive dividend, management indicated surplus capital may be deployed via share buybacks or disciplined M&A. The board’s 5% interim dividend increase to 1.05 cents per share reflects confidence in medium-term cash flow and prospects. The combination of low capital intensity and flexible cost base supports confidence in achieving the $1 billion cumulative free cash flow target even under modest growth scenarios.

Full-Year 2026 Guidance Maintained with Expectations for Earnings Growth and Cost Savings

Coats reaffirmed its full-year 2026 guidance despite H1 results, anticipating modest market declines in H2 amid low inventory levels across supply chains. The Group expects to outperform the market through share gains, pricing, target adjacencies, and new product launches. Incremental cost actions, including OrthoLite synergies, are expected to yield approximately $15 million in H2 benefits. Management forecasts solid year-on-year earnings growth for 2026, with EPS guidance indicating expansion relative to 2025 despite strong H1 2025 comparators.

The medium-term financial framework, updated in March 2026, targets revenue growth exceeding 5% on average through the cycle with 200 basis points of market outperformance, EBIT margins of 21-23%, total EPS CAGR above 10%, and cumulative free cash flow of about $1 billion over five years. While recognizing that 2026 revenue growth may fall short of 5% due to market uncertainty, H1 performance demonstrates consistent market share gains and growth in adjacencies aligned with the framework. Prudence has been built into EBIT margin and cash flow targets to ensure achievability under modest growth scenarios.

Innovation Pipeline and Upcoming Product Launches to Drive Growth in H2 and Beyond

Innovation remains central to Coats’ growth strategy, with several new products launched in H1 2026 or planned for H2, focusing on target adjacency markets. Recent successes include composite anti-wear tape for oil and gas pipelines, securing its first global oil services customer and attracting additional prospects. Signal Lucence PRO "glow in the dark" technology, acquired via VizLite, has been specified for the UK National Fire Chiefs Council’s eight-year Personal Protective Equipment Framework to enhance firefighter visibility in low-visibility conditions, with first implementation expected in H2 2026 and a $20 million revenue opportunity.

Within Footwear, a strong pipeline of new products is set to launch in H2 2026 and 2027, supported by divisional restructuring and talent investments made in H2 2025. The OrthoLite acquisition has expanded innovation capacity for new insole technologies targeting premium and sustainable segments. New secured customer launches are expected to complement existing OrthoLite sales in H2, alongside early revenues from four major growth initiatives. Management emphasizes ongoing investment in innovation and operational excellence to sustain competitive differentiation and support medium-term revenue growth.

Medium-Term Financial Targets Combine Ambitious Growth with Conservative Margins

Announced in March 2026, Coats’ updated medium-term financial targets balance ambitious growth with conservative market assumptions. The revenue growth goal of over 5% on average through the cycle, including 200 basis points of market outperformance, reflects confidence in market share gains and adjacency expansion. The EBIT margin target of 21-23% represents a 130-230 basis point increase from current levels, to be achieved through commercial and operational excellence and margin benefits from OrthoLite integration and synergies.

The total EPS CAGR target above 10% from 2026 positions earnings growth to exceed revenue increases, driven by margin expansion and disciplined capital allocation. The cumulative free cash flow target of approximately $1 billion over five years reflects sustainable cash generation supported by low capital intensity and cost flexibility. Management stresses prudence in EBIT margin and cash flow targets to ensure feasibility even with modest revenue growth, providing investor confidence across market cycles.